{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:47:06Z","timestamp":1771642026728,"version":"3.50.1"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>New diagnostic criteria for lifelong premature ejaculation (PE) have been proposed by the International Society of Sexual Medicine (ISSM), including an intravaginal ejaculatory latency time (IELT) of less than about 1 minute, lack of control over ejaculation, and PE-related distress or bother.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The aim of this study was to review evidence supporting the efficacy and safety of oral agents for the treatment of PE in the context of the new ISSM criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The PubMed database was searched for randomized, double-blind, placebo-controlled studies of oral agents in PE that included stopwatch measurements of IELT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>The main outcome measure used for this study was a review of the efficacy and safety data of oral agents for PE aligned with ISSM criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Since the latest meta-analyses using similar criteria (conducted in 2004 and 2005 for selective serotonin reuptake inhibitors [SSRIs] and phosphodiesterase type 5 [PDE-5] inhibitors, respectively), eight studies evaluated SSRIs vs. placebo, one compared SSRIs, two evaluated PDE-5 inhibitors, and one evaluated an SSRI\/PDE-5 inhibitor combination. New agents included dapoxetine (five studies) and tramadol (one study). Six studies enrolled men who met an approximation of the ISSM criteria. Although evidence suggests that most SSRIs, tramadol, and dapoxetine increase IELT to varying degrees, few studies included control over ejaculation and PE-related distress or bother as enrollment criteria or used validated patient-reported outcome instruments to evaluate these parameters. Among studies that provided comprehensive adverse event data, safety and tolerability observations in men with PE were generally similar to those observed in other populations; however, with the exception of dapoxetine, known SSRI-class effects (e.g., withdrawal syndrome) were not evaluated in men with PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This systematic review of well-controlled clinical trials in PE has demonstrated that while many oral agents, particularly SSRIs, tramadol, and dapoxetine, have proven effective and safe for the treatment of men with PE, few have been evaluated for their effects on the specific elements of the ISSM criteria.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02386.x","type":"journal-article","created":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T23:12:32Z","timestamp":1311117152000},"page":"2707-2725","source":"Crossref","is-referenced-by-count":30,"title":["Oral Agents for the Treatment of Premature Ejaculation: Review of Efficacy and Safety in the Context of the Recent International Society for Sexual Medicine Criteria for Lifelong Premature Ejaculation"],"prefix":"10.1093","volume":"8","author":[{"given":"C. G.","family":"McMahon","sequence":"first","affiliation":[{"name":"Australian Centre for Sexual Health , St. Leonards, NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Porst","sequence":"additional","affiliation":[{"name":"Private Urology and Andrology Practice and Hospital , Hamburg, , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"key":"2023012309044901600_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1743-6109.2007.00638.x","article-title":"Urologist practice patterns in the management of premature ejaculation: A nationwide survey","volume":"5","author":"Shindel","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1743-6109.2008.00831.x","article-title":"Premature ejaculation: Current medical treatment and new directions (CME)","volume":"5","author":"Sadeghi-Nejad","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ncpuro1016","article-title":"Ejaculatory disorders: Pathophysiology and management","volume":"5","author":"Bettocchi","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"2023012309044901600_bb0025","first-page":"402","article-title":"A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples","volume":"56","author":"Althof","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"2023012309044901600_bb0030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.5694\/j.1326-5377.2008.tb01827.x","article-title":"Premature ejaculation: A clinical update","volume":"188","author":"Palmer","year":"2008","journal-title":"Med J Aust"},{"key":"2023012309044901600_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000475036","article-title":"Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy","volume":"28","author":"Cavallini","year":"1995","journal-title":"Eur Urol"},{"key":"2023012309044901600_bb0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s11255-005-3616-4","article-title":"Terazosin in the treatment of premature ejaculation: A short-term follow-up","volume":"37","author":"Basar","year":"2005","journal-title":"Int Urol Nephrol"},{"key":"2023012309044901600_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1743-6109.2006.00424.x","article-title":"Tramadol HCL has promise in on-demand use to treat premature ejaculation","volume":"5","author":"Salem","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0050","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1111\/j.1743-6109.2010.01789.x","article-title":"Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation","volume":"7","author":"Alghobary","year":"2010","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1745-7262.2008.00369.x","article-title":"Premature ejaculation: Current and future treatments","volume":"10","author":"Gurkan","year":"2008","journal-title":"Asian J Androl"},{"key":"2023012309044901600_bb0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: Integrated analysis of two randomized, double-blind, placebo-controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"2023012309044901600_bb0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"2023012309044901600_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: Results from a placebo-controlled phase III trial","volume":"103","author":"Kaufman","year":"2009","journal-title":"BJU Int"},{"key":"2023012309044901600_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","article-title":"Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine","volume":"7","author":"McMahon","year":"2010","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0080","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1743-6109.2008.00901.x","article-title":"An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Definition of Premature Ejaculation","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0085","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1743-6109.2008.00837.x","article-title":"Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-part II-study design, outcome measures, data analysis, and reporting","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1743-6109.2009.01623.x","article-title":"Standards for clinical trials in male sexual dysfunctions","volume":"7","author":"Porst","year":"2010","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0095","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1743-6109.2008.00836.x","article-title":"Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies\u2014Part I\u2014Defining and selecting the study population","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","article-title":"Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis","volume":"16","author":"Waldinger","year":"2004","journal-title":"Int J Impot Res"},{"key":"2023012309044901600_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"2023012309044901600_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"2023012309044901600_bb0115","first-page":"116","article-title":"Selective serotonin re-uptake inhibitor in the treatment of premature ejaculation","volume":"28","author":"Novaretti","year":"2002","journal-title":"Braz J Urol"},{"key":"2023012309044901600_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000112607","article-title":"Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study","volume":"80","author":"Mattos","year":"2008","journal-title":"Urol Int"},{"key":"2023012309044901600_bb0125","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0022-5347(01)65467-3","article-title":"The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo controlled study","volume":"156","author":"Kara","year":"1996","journal-title":"J Urol"},{"key":"2023012309044901600_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11255-006-6659-2","article-title":"The efficacy of duloxetine in the treatment of premature ejaculation","volume":"39","author":"Athanasios","year":"2007","journal-title":"Int Urol Nephrol"},{"key":"2023012309044901600_bb0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.ijir.3900918","article-title":"The efficacy of citalopram in the treatment of premature ejaculation: A placebo-controlled study","volume":"14","author":"Atmaca","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309044901600_bb0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00004714-199808000-00004","article-title":"Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline","volume":"18","author":"Waldinger","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"2023012309044901600_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00004714-200106000-00007","article-title":"Antidepressants and ejaculation: A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone","volume":"21","author":"Waldinger","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"2023012309044901600_bb0155","article-title":"US FDA draft guidance for industry, patient reported outcome measures: Use in medical product development to support labeling claims","author":"US Food and Drug Administration (FDA)","year":"2009"},{"key":"2023012309044901600_bb0160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1743-6109.2006.00239.x","article-title":"Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation","volume":"3","author":"Althof","year":"2006","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0170","first-page":"119","article-title":"The \u201cPEQUEST\u201d: A multidimensional instrument for the assessment of premature ejaculation","volume":"8","author":"Hartmann","year":"1996","journal-title":"Int J Impot Res"},{"key":"2023012309044901600_bb0175","first-page":"121","article-title":"Sexual function of premature ejaculation patients assayed with Chinese Index of Premature Ejaculation","volume":"6","author":"Yuan","year":"2004","journal-title":"Asian J Androl"},{"key":"2023012309044901600_bb0180","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1743-6109.2006.00213.x","article-title":"Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE)","volume":"4","author":"Arafa","year":"2007","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0185","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.juro.2006.10.044","article-title":"Correlates to the clinical diagnosis of premature ejaculation: Results from a large observational study of men and their partners","volume":"177","author":"Rosen","year":"2007","journal-title":"J Urol"},{"key":"2023012309044901600_bb0190","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1743-6109.2005.20353.x","article-title":"Premature ejaculation: An observational study of men and their partners","volume":"2","author":"Patrick","year":"2005","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0195","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2023012309044901600_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): A state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023012309044901600_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-199610000-00006","article-title":"An open clinical trial of fluoxetine in the treatment of premature ejaculation","volume":"16","author":"Lee","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"2023012309044901600_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.ijir.3901023","article-title":"Towards evidence-based drug treatment research on premature ejaculation: A critical evaluation of methodology","volume":"15","author":"Waldinger","year":"2003","journal-title":"Int J Impot Res"},{"key":"2023012309044901600_bb0215","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.eururo.2007.08.005","article-title":"The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: A critical analysis of basic science and clinical data","volume":"52","author":"Chen","year":"2007","journal-title":"Eur Urol"},{"key":"2023012309044901600_bb0220","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","article-title":"International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0225","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1743-6109.2010.01782.x","article-title":"Disorders of orgasm and ejaculation in men","volume":"7","author":"Rowland","year":"2010","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1464-410X.2008.08041.x","article-title":"The Premature Ejaculation Profile: Validation of self-reported outcome measures for research and practice","volume":"103","author":"Patrick","year":"2009","journal-title":"BJU Int"},{"key":"2023012309044901600_bb0235","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1743-6109.2010.01820.x","article-title":"Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: Integrated analyses of two phase 3 dapoxetine trials","volume":"7","author":"Porst","year":"2010","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0240","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/S0022-5347(05)64174-2","article-title":"A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation","volume":"168","author":"Salonia","year":"2002","journal-title":"J Urol"},{"key":"2023012309044901600_bb0245","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1743-6109.2007.00528.x","article-title":"The majority of men with lifelong premature ejaculation prefer daily drug treatment: An observation study in a consecutive group of Dutch men","volume":"4","author":"Waldinger","year":"2007","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0250","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1185\/030079906X132415","article-title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: A meta-analysis of head-to-head trials","volume":"22","author":"Machado","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"2023012309044901600_bb0255","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004714-199610000-00003","article-title":"Serotonin reuptake inhibitor withdrawal","volume":"16","author":"Coupland","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"2023012309044901600_bb0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004850-200015060-00003","article-title":"An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram","volume":"15","author":"Markowitz","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"2023012309044901600_bb0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2490-5-18","article-title":"Indirect comparison of interventions using published randomised trials: Systematic review of PDE-5 inhibitors for erectile dysfunction","volume":"5","author":"Moore","year":"2005","journal-title":"BMC Urol"},{"key":"2023012309044901600_bb0270","author":"Hytrin","year":"2006","journal-title":"Hytrin (terazosin hcl tablets) [package insert]"},{"key":"2023012309044901600_bb0275","first-page":"543","article-title":"Tramadol for osteoarthritis: A systematic review and metaanalysis","volume":"34","author":"Cepeda","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"2023012309044901600_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-199700532-00010","article-title":"[Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance]","volume":"53","author":"Cossmann","year":"1997","journal-title":"Drugs"},{"key":"2023012309044901600_bb0285","first-page":"72","article-title":"Clinical inquiries. What is the addiction risk associated with tramadol?","volume":"54","author":"McDiarmid","year":"2005","journal-title":"J Fam Pract"},{"key":"2023012309044901600_bb0290","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpainsymman.2005.10.006","article-title":"A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain","volume":"31","author":"Adams","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"2023012309044901600_bb0295","article-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"2023012309044901600_bb0300","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.ju.0000132159.61156.ea","article-title":"AUA guideline on the pharmacologic management of premature ejaculation","volume":"172","author":"Montague","year":"2004","journal-title":"J Urol"},{"key":"2023012309044901600_bb0305","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1743-6109.2004.10109.x","article-title":"Disorders of orgasm and ejaculation in men","volume":"1","author":"McMahon","year":"2004","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0310","article-title":"MedDRA\u2014Medical Dictionary for Regulatory Activities (Ver 10.1)","author":"MedDra","year":"2008"},{"issue":"6","key":"2023012309044901600_bb0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-199807006-00003","article-title":"Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour","volume":"13","author":"Olivier","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"2023012309044901600_bb0320","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0166-4328(97)00183-6","article-title":"Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: The involvement of the serotonergic system","volume":"92","author":"Waldinger","year":"1998","journal-title":"Behav Brain Res"},{"key":"2023012309044901600_bb0325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00042307-199911000-00011","article-title":"Pharmacological treatment of premature ejaculation","volume":"9","author":"McMahon","year":"1999","journal-title":"Curr Opin Urol"},{"key":"2023012309044901600_bb0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1743-6109.2005.20112.x","article-title":"On-demand SSRI treatment of premature ejaculation: Pharmacodynamic limitations for relevant ejaculation delay and consequent solutions","volume":"2","author":"Waldinger","year":"2005","journal-title":"J Sex Med"},{"key":"2023012309044901600_bb0335","author":"PAXIL r (paroxetine hydrochloride) Tablets and Oral Suspension [package insert]","year":"2007"},{"key":"2023012309044901600_bb0340","author":"ZOLOFT r (sertraline hydrochloride) Tablets and Oral Concentrate [package insert]","year":"2005"},{"key":"2023012309044901600_bb0345","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0091270005284850","article-title":"Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation","volume":"46","author":"Modi","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"2023012309044901600_bb0350","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2009.01.026","article-title":"Editorial comment on: Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Jannini","year":"2009","journal-title":"Eur Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515332926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515332926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/10\/2707\/48607486\/jsm_8_10_2707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/10\/2707\/48607486\/jsm_8_10_2707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T09:30:25Z","timestamp":1674466225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/8\/10\/2707\/6980223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,1]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02386.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,10,1]]}}}